Medical automation refers to the technology that is used to minimize error, promote management of chronic illness. It controls the diagnostics, monitoring and therapeutic machineries that servers the major responsive tasks into the hospital. It also increases the possibilities of the predictable outcome when patients follow a standardization care path supported by automation. The increasing demand for reliable and accurate medical procedures, increasing labour cost, and the increasing investments by the government are contributing to the market growth.This growth is primarily driven by Rise In Demand for Reproducibility and Accuracy and Rising Government Regulation for Medical Automation.
Globally, a noticeable market trend is evident Technological Advancements to Boost the Adoption of Medical Automation. Major Players, such as Koninklijke Philips N.V. (Netherlands), General Electric Company (United States), Siemens AG (Germany), Accuray Incorporated (United States), Intuitive Surgical, Inc. (United States), Stryker Corporation (United States), Swisslog Holding AG (Switzerland) and Danaher Corporation (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Robotically assisted surgeries are used to aid in surgical procedures to overcome the limitations of pre-existing minimal invasive surgical procedures to enhance capabilities of the surgeons, which include neurological, gynaecological, cardiac and orthopaedic. Robotic assist surgeries with precision, miniaturization, smaller incisions such as decreased blood loss, less pain, and quick healing time, which significantly reduces the hospital stay and blood transfusion. According to the health research funding organization, the rate of robotic surgeries is increasing by 25% annually and in 2012, approximately 400,000 robotic surgeries were performed across U.S.
According to the World Health Organization (WHO) with chronic diseases being one of the leading factors of mortality in world, chronic conditions such as cancer, stroke, heart disease, diabetes, and respiratory diseases cause approximately 60% of the deaths. Moreover, as per NCBI by 2030, approximately 40.5% of U.S. population is projected to face one or more cardiovascular diseases, thereby enlarging the consumer base for this market.
- Rise In Demand for Reproducibility and Accuracy
- Rising Government Regulation for Medical Automation
- Technological Advancements to Boost the Adoption of Medical Automation
- Stringent Government Rules and Regulation
Automation in Cancer Research for Early Cancer Detection and Reducing Cost of Cancer Treatment and Care
Survival of Small Players and New Entrants
AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization of the Report:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase